Anebulo Pharmaceuticals
ANEB
ANEB
14 hedge funds and large institutions have $18.6M invested in Anebulo Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Morgan Stanley
New York
|
+$1.93M |
2 |
2L
22NW LP
Seattle,
Washington
|
+$726K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$316K |
4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$36.3K |
5 |
Bank of America
Charlotte,
North Carolina
|
+$10 |
Top Sellers
1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.22M |
2 |
PP
Praetorian PR
Rincon,
Puerto Rico
|
-$542K |
3 |
LA
LVW Advisors
Pittsford,
New York
|
-$70.9K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$28.4K |
5 |
BlackRock
New York
|
-$116 |